on 21 Jun 2016
Last Applicant/ Owned by
Harston Cambridge CB22 7GG
Serial Number
79173176 filed on 06th Jan 2015
Registration Number
4980399 registered on 21st Jun 2016
Correspondent Address
Karl M. Zielaznicki, Esq.
Troutman Pepper Hamilton Sanders LLP
c/o TM DKT CLK
600 Peachtree Street, NE, Suite 3000
Atlanta GA 30308-2216
Filing Basis
1. filing basis filed as 66 a
Disclaimer
"PHARMA"
Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluation, development and testing services; pharmaceutical research, inspection and testing; medical and pharmaceutical research services; scientific research foRead More
Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of repurposing existing drugs for new therapeutic uses; pharmaceutical and veterinary product evaluation, development and testing services; pharmaceutical research, inspection and testing; medical and pharmaceutical research services; scientific research for medical purposes in the area of cancerous disease; pharmaceutical research, inspection, testing, development and evaluation of pharmaceutical and veterinary preparations, sanitary preparations for medical purposes, dietetic food and substances adapted for medical or veterinary use, pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV), pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV), pharmaceutical preparations for the management of xerostomia (dry mouth), pharmaceutical preparations for the management of cancer cachexia, pharmaceutical preparations for the management of cancer treatment side effects, pharmaceutical preparations for the management of side effects of surgery, pharmaceutical preparations for the management of cancer side effects, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations associated with surgery; information, advisory and consultancy services relating to the aforementioned services
Sanitary preparations for medical purposes; pharmaceutical preparations for the management of post-operative nausea and vomiting (PONV); pharmaceutical preparations for the management of chemotherapy induced nausea and vomiting (CINV); pharmaceutical preparations for the management of xerostomia (dry mouth); pharmaceutical preparations for the management of cancer cachexia; pharmaceutical preparations for the management of cancer treatment side effects; pharmaceutical preparations for the management of side effects of surgery; pharmaceutical preparations for the management of cancer side effects; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations associated with surgery
No 79173176
No Service Mark
No 259527040006
No
No
No
No
Yes
Yes
No
No
26.01.21 -
Circles that are totally or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the stylized wording "ACACIA PHARMA" and the stylized design of an irregular oval shape with a block positioned above it that has a pointed end at the left edge and a flat end at the right edge. The design and word "ACACIA" are in black and the word "PHARMA" is in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Status Date | Action Taken |
---|---|
11th Oct 2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
25th Aug 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
04th Jun 2023 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
03rd Sep 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
05th Aug 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
05th Aug 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
05th Aug 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
05th Aug 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
06th Jun 2022 | TEAS SECTION 71 RECEIVED |
18th Feb 2022 | NEW REPRESENTATIVE AT IB RECEIVED |